StockData

Health In Tech vs Zhibao Technology

HIT and ZBAO side by side, both in insurance agents, brokers, and service. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How HIT and ZBAO compare

Health In Tech grew revenue faster over the last twelve months (23.0% versus 15.5% for Zhibao Technology).

Zhibao Technology keeps more of each dollar of sales as profit, with a net margin of −0.83% compared with −12.0% at Health In Tech.

Health In Tech scores higher on the StockData Score (3 against 2 for Zhibao Technology), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricHITZBAO
Size and price
Market cap$25.0M–
Share price$0.382$0.183
Change, 1 year−76.1%−99.6%
Beta (5Y)0.413.31
Employees8765
StockData Score
Total score3 (better)2
Valuation score1 (better)0
Growth score11
Performance score01 (better)
Health score1 (better)0
Dividend score00
Valuation
P/S0.8×–
Growth
Revenue growth (TTM)23.0% (better)15.5%
Revenue growth, 5Y average–782%
Net income growth (TTM)−390%–
EPS growth (TTM)−333%–
Profitability
Gross margin53.9% (better)38.7%
Operating margin–2.9%
Net margin−12.0%−0.83% (better)
Return on equity−24.0%−10.8% (better)
Return on invested capital–20.1%
Financial health
Net debt / EBITDA–3.15
Current ratio2.18 (better)0.96
Altman Z-score3.14–
Piotroski F-score6 (better)3
Dividends and buybacks
Shareholder yield0.00%–
Ownership
Held by institutions7.1%0.01%
Held by insiders90.6%72.3%
Insider net buying, 12 months−$40.6K–
Short interest, % of float9.8%–

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.